samedan logo

 
 
spacer
home > white papers > The Importance of ADCC in Assessing Clinically Relevant Differences - Sartorius Stedim BioOutsource Ltd
WHITE PAPERS

Sartorius Stedim BioOutsource Ltd

phone +44 (0)141 946 4222
web http://www.biooutsource.com
email 1 Technology Terrace, Todd Campus, West of Scotland Science Park, Glasgow, G20 0XA, UK

The Importance of ADCC in Assessing Clinically Relevant Differences

Biosimilars have caused a revolution in the development of biologic drugs. The model for biosimilars is a combination of speed to market and low cost; these are fundamental to any biosimilar development project. The biosimilars pathway to approval is not always without difficulty, biosimilars are still relatively new, and as each new applicant is reviewed we are learning more and more about these molecules.
The Importance of ADCC in Assessing Clinically Relevant Differences
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Cargolux pledges millions to support Ukraine

Luxembourg, 4 March 2022 Cargolux will donate a total of EUR 3.5 million to support humanitarian efforts arising from the war in Ukraine. This monetary assistance follows the UNs emergency appeal for US$1.7 billion to urgently deliver humanitarian support to people in Ukraine and those who have fled the country in search of safety and protection.
More info >>


White Papers

Soothing the Logistical Headache of Clinical Trials

Equilibrium Travel Management

As many as 30 per cent of subjects on phase three clinical studies drop out.  Gruelling schedules, high travel costs and time waiting for expense reimbursement can all be factors in these fall rates, and this can be very problematic, delaying or even leading to the cancellation of the trial.  It is crucial to keep subjects motivated, and through efficient travel and expense management, this can be achieved.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement